Literature DB >> 11256848

Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management.

G Assmann1.   

Abstract

Risk assessment limited to low-density lipoprotein cholesterol (LDL-C) levels fails to identify a substantial proportion of individuals at risk for coronary artery disease. Data from the Prospective Cardiovascular Münster (PRO-CAM) study indicate that triglyceride levels and high-density lipoprotein cholesterol levels are important determinants of risk irrespective of LDL-C level. Risk is most accurately predicted using an algorithm incorporating multiple risk factors, as shown by the multiple logistic function analysis using the independent risk variables identified on multivariate analysis in PROCAM. It remains unclear what effect statin therapy to decrease LDL-C has in individuals with risk associated with factors other than elevated LDL-C. Such individuals might derive preferential benefit from treatments targeting such risk factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11256848     DOI: 10.1016/s0002-9149(01)01448-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  Therapeutic reduction of coronary atheromatous plaque burden using bioengineered apoA-I Milano.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

3.  Impact of lowering triglycerides on raising HDL-C in hypertriglyceridemic and non-hypertriglyceridemic subjects.

Authors:  Michael Miller; Patricia Langenberg; Stephen Havas
Journal:  Int J Cardiol       Date:  2006-10-18       Impact factor: 4.164

4.  Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087.

Authors:  Scott R Evans; Carl J Fichtenbaum; Judith A Aberg
Journal:  HIV Clin Trials       Date:  2007 Jan-Feb

Review 5.  Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.

Authors:  Luke J Leman; Bruce E Maryanoff; M Reza Ghadiri
Journal:  J Med Chem       Date:  2013-10-29       Impact factor: 7.446

6.  Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins.

Authors:  Motoki Yamashita; Atsushi Iwata; Yuta Kato; Makito Futami; Satoshi Imaizumi; Takashi Kuwano; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Bo Zhang; Shin'ichiro Yasunaga; Keijiro Saku; Shin-Ichiro Miura
Journal:  Heart Vessels       Date:  2018-04-25       Impact factor: 2.037

Review 7.  Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Authors:  Marc Evans; Aled Roberts; Steve Davies; Alan Rees
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Cardiometabolic Risk Profile Among Young Adult Females With a History of Premature Adrenarche.

Authors:  Jani Liimatta; Pauliina Utriainen; Tomi Laitinen; Raimo Voutilainen; Jarmo Jääskeläinen
Journal:  J Endocr Soc       Date:  2019-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.